Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04586335
Recruitment Status : Recruiting
First Posted : October 14, 2020
Last Update Posted : February 8, 2021
Information provided by (Responsible Party):
Haihe Biopharma Co., Ltd.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 28, 2024
Estimated Study Completion Date : January 28, 2024